CEREZYME®
CEREZYME® is the ONLY ERT (enzyme replacement therapy) that has shown long-term efficacy and safety in multiple studies over 20 years and has been prescribed for over 25 years.
Administration and Dosage:
Therapy with Cerezyme should be directed by physicians knowledgeable in the management of patients with Gaucher disease.
The recommended dosage of Cerezyme based upon disease severity ranges from 2.5 units/kg three times a week to 60 units/kg once every two weeks. For patients weighing 18 kg and greater, infuse the diluted Cerezyme solution over 1 to 2 hours. For patients weighing less than 18 kg, infuse the diluted Cerezyme solution over 2 hours.
Common Side Effects:
Adverse reactions reported in adults include back pain, chills, dizziness,
fatigue, headache, hypersensitivity reactions, nausea, pyrexia, and
vomiting.Adverse reactions reported in pediatric patients 2 years of age and older are similar to adults.
More information:
Please see full Prescribing Information including Patient Information.
Indication:
Cerezyme® (imiglucerase) for injection is indicated for treatment of adults and pediatric patients 2 years of age and older with Type 1 Gaucher disease that results in one or more of the following conditions:
anemia (low red blood cell count)
thrombocytopenia (low blood platelet count)
bone disease
hepatomegaly or splenomegaly (enlarged liver or spleen)
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!
Check our Privacy Practice